Transforming Diagnostics in GI Infections: The Role of Molecular Testing
SUMMARY
Medical Laboratory Observer | October 2024
Gain valuable insights into the pressing challenge of diagnosing gastrointestinal infections (GI) in the context of antimicrobial resistance (AMR). In this exclusive article, David Allen, PharmD, BCIDP, examines how innovative molecular diagnostics are transforming clinical practices, enabling faster and more accurate identification of pathogens. Dr. Allen addresses the significant benefits these advancements bring to patient outcomes and antimicrobial stewardship (AMS) efforts, helping healthcare professionals stay informed on the latest developments in this critical area.
FEATURED EXPERTS
David Allen, PharmD, BCIDP, Field Medical Director, bioMérieux
GET STARTED
Discover how molecular diagnostics are improving the management of gastrointestinal infections.
PUBLISHED BY
January 08, 2025